The three studies suggested that the incidence of driver gene mutations in NSCLC patient is high, and lung cancer driver genes, such as EGFR, ALK, and RET are risk factors for brain metastasis in advanced NSCLC patients. This evidence concerns the gene RET and lung carcinoma.